Save the Date -
8th Annual Spring to Life Conference

Hematologic Malignancies 2021

Mark your calendar for April 17, 2021!

If you are not already on our email list, click here to be notified when registration opens.

Proudly Hosted by New York Oncology Hematology, PC

PROUDLY HOSTED BY:

EVENT INFORMATION

The LIVE online event Spring to Life Conference on Lung Cancer 2020 was held on October 10, 2020
On-Demand recording of the LIVE conference is available until November 10th!
Information for earning your CME credits will be emailed to you after the on-demand period ends
Upon registration, confirmation, and receipt of payment will be provided via email
Login information and instructions will be emailed to you

Next quote »

"Identification of molecular drivers has resulted in tailored treatments for our patients with non-small cell lung cancer which are not only more effective, but less toxic. It is essential the community oncologist have a keen knowledge of the most current precision testing techniques and incorporate newer therapies to provide state-of-the-art care to patients close to home."

-Makenzi Evangelist, M.D., New York Oncology Hematology

“The landscape of lung cancer with new biomarkers, immunotherapies, and targeted therapies is constantly evolving, and it is a challenge for the community oncologist to integrate and apply this new knowledge in daily clinical practice. Accessible continuing education forums are crucial to support this rapid evolution of cancer care."

-Nischala Ammannagari, M.D., New York Oncology Hematology

Registration

Please click here if you would like to be notified when registration is open. We hope to see you in 2020!

S2L | Registration HCP

First Name *

Last Name

Title Title

Specialty

Institution *

Address *

2nd Address

City *

State *

ZIP *

Phone

How did you hear about the conference? * How did you hear about the conference?

reCAPTCHA

Conference Platform

The 2020 Spring to Life conference is being held live online utilizing a multimedia webcast and virtual conference platform to livestream the keynote, plenary sessions and ancillary events along with moderated Q&A panel discussions. The sponsors and exhibitors of the conference will be available for attendees to visit during the duration of the conference in the Virtual Trade Show hall. The conference will be recorded and will be offered on-demand for 30 days following the conference.

PROGRAM OVERVIEW

The focus of the 2020 Spring to Life live online Conference is Lung Cancer. New York Oncology Hematology (NYOH) has identified an ongoing unmet need for medical education in the area of lung cancer. To meet this need, NYOH, in collaboration with The University of Chicago Pritzker School of Medicine, myMedEd, Inc. and a panel of expert faculty from the academic, research, and community practice settings, developed an accredited, multi-supported educational conference. This is the seventh of these annual conferences that include programming for cancer clinicians.

EDUCATIONAL GOAL

The purpose of this conference is to educate practitioners and update their knowledge of existing and emerging therapies for the management of patients with lung cancer.

TARGET AUDIENCE

The target audience for this conference is medical oncologists, radiation oncologists, surgical oncologists, thoracic surgeons, pulmonologists, radiologists, interventional radiologists, pathologists, oncology nurses, advanced practice providers, family and primary care practitioners, allied health professionals, and any other individuals with an interest in the care of patients with lung cancer.

LEARNING OBJECTIVES

After completing this activity, participants will be able to:

Describe current and evolving management strategies for patients with localized and locally advanced, non-small cell lung cancer.
Identify best practices in biomarker testing and the utilization of biomarkers to drive treatment decisions for patients with lung cancer.
Explain the application of targeted therapy and immunotherapy in the treatment of NSCLC.
Outline the clinical trial data on the use of molecular drivers in the management of patients with advanced, non-small cell lung cancer.
Summarize current and emerging strategies in the management of patients with advanced, non-small cell lung cancer without driver mutations.

DOWNLOAD AGENDA

PLANNING COMMITTEE

Ira Zackon, MD
New York Oncology Hematology – President
Hematologist/Medical Oncologist
NYOH Hematology Stem Cell Transplant Program
NYOH Albany Medical Center
Clinical Assistant Professor
Albany Medical College
Albany, NY

Makenzi Evangelist, MD
Medical Oncologist/Hematologist
NYOH Albany Medical Center
Hematology/Oncology Division Head
Albany Medical Center
Clinical Assistant Professor
Albany Medical College
Albany, NY

Nischala Ammannagari, MD

Medical Oncologist/Hematologist
NYOH Albany Cancer Center
Albany, NY

Faculty

Jamie Chaft, MD
Associate Attending Physician
Memorial Sloan Kettering Cancer Center
New York, NY

Ibiayi Dagogo-Jack, MD

Thoracic Oncologist
Massachusetts General Hospital
Boston, MA

Justin Juliano, MD
Radiation Oncologist
NYOH Clifton Park
Clifton Park, NY

Elizabeth Marshall, MD
Thoracic Surgeon
St. Peter’s Health Partners Medical Associates
Albany, NY

Paul K. Paik, MD

Clinical Director, Thoracic Oncology Service
Associate Attending Physician
Memorial Sloan Kettering Cancer Center
New York, NY

Alex Spira, MD, PhD, FACP
Director of Clinical Research, Medical Oncologist
Virginia Cancer Specialists
Fairfax, VA

Ajay A. Wagh, MD, MS, FCCP

Interventional Pulmonologist
Assistant Professor of Medicine
Division of Pulmonary and Critical Care Medicine
University of Chicago
Chicago, IL

Michael D. Robek, PhD

Professor
Department of Immunology & Microbial Disease
Albany Medical College
Albany, NY

Stephen H. Wrzesinski MD, PhD

Director of Immunooncology and Cellular Therapies
New York Oncology Hematology
Clinical Assistant Professor of Medicine
Albany Medical Center
Albany, NY

Ira Zackon, MD (Chair)

Medical Hematology and Oncology Director
NYOH Hematology Stem Cell Transplant Program
Hematologist/Oncologist NYOH
Clinical Assistant Professor
Albany Medical College
Albany, NY

The 2020 Spring to Life conference is being held online utilizing a multimedia webcast and virtual conference platform to livestream the keynote, plenary sessions and ancillary events. The conference will be recorded and will be offered on-demand for 30 days following the conference.

A virtual trade show platform is available to exhibitors and offers the opportunity to include a video presentation, literature, live chat, messaging and the organization’s Twitter feed. Exhibitors can design their own booth or request it be designed for them. Conference attendees can visit booths and interact with exhibitors during the conference and the virtual trade show will remain live for 30 days following the conference.

To pay via credit card, please go to: https://cmersvp.com/exhibit-processing-form/ and complete the form and credit card payment.

To pay by check, complete the online form at https://cmersvp.com/exhibit-processing-form/, indicate you intend to pay via check on the form and make checks payable to:

myMedEd, Inc.

518 S. IL Route 31 #194

McHenry, IL 60050

TAX ID: 82-4893155

If a letter of request and/or W9 is needed, please contact us and we will provide you with the additional documentation you need. Phone Number: 1-800-973-0665
Email: exhibits@mymededco.com

Host

The 7th Annual Spring to Life™ Conference on Lung Cancer is proudly hosted by
New York Oncology Hematology, PC

ACCREDITATION

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and New York Oncology Hematology, PC, and in collaboration with myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.

Assurance of Balanced, Unbiased, and Fair Content:

It is the policy of The University of Chicago Pritzker School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its individually provided or jointly provided educational activities. Individuals who are in a position to control the content of any educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.